Evidence map›Paper›PMID 31610061›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2020

YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling.

Christopher D Kegelman, Jennifer C Coulombe, Kelsey M Jordan, Daniel J Horan, Ling Qin, Alexander G Robling, Virginia L Ferguson, Teresita M Bellido, Joel D Boerckel

Abstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Christopher D KegelmanDepartment of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-5359-7128
Jennifer C CoulombeDepartment of Mechanical Engineering, University of Colorado, Boulder, CO, USA.
Kelsey M JordanDepartment of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA.
Daniel J HoranDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
Ling QinDepartment of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-2582-0078
Alexander G RoblingDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0002-3989-4780
Virginia L FergusonDepartment of Mechanical Engineering, University of Colorado, Boulder, CO, USA.
Teresita M BellidoDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0002-8203-7004
Joel D BoerckelDepartment of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-3126-3025
University of Pennsylvania · USIndiana University School of MedicineUniversity of Colorado Boulder · US

Funding

Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)P30AR069619 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI LOUIS J SOSLOWSKY · 2016 to 2026
$9.1M
The Role of Hyaluronic Acid Receptors in Tendon HealingP30AR050950 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI ELLIOTT, DAWN M · 2006 to 2015
$6.2M
Training Program in Musculoskeletal ResearchT32AR007132 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Robert L Mauck, LOUIS J SOSLOWSKY · 1986 to 2026
$4.9M
Glucocorticoid-induced Atrophy in Bone and MuscleR01AR059357 · NIAMS · UNIV OF ARKANSAS FOR MED SCIS · PI BELLIDO, TERESITA M. · 2011 to 2022
$3.4M
Mechanisms of Osteocyte Mechanotransduction in Dynamic Bone AdaptationR21AR071559 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI BOERCKEL, JOEL D · 2018 to 2019
$384k
BLR&D Research Career Scientist Award Application for Teresita Bellido, PhDIK6BX004596 · VA · RLR VA MEDICAL CENTER · PI BELLIDO, TERESITA M. · 2019 to 2025
–
PTH receptor Signaling and Diabetes-induced Bone DiseaseI01BX002104 · VA · RLR VA MEDICAL CENTER · PI BELLIDO, TERESITA M. · 2014 to 2023
–
BLRD VA I01 BX002104BLRD VA IK6 BX004596NIAMS NIH HHS P30 AR050950NIAMS NIH HHS P30 AR069619NIAMS NIH HHS R01 AR059357NIAMS NIH HHS R21 AR071559NIAMS NIH HHS T32 AR007132
6 · The paper itself

Abstract

Bone fragility fractures are caused by low bone mass or impaired bone quality. Osteoblast/osteoclast coordination determines bone mass, but the factors that control bone quality are poorly understood. Osteocytes regulate osteoblast and osteoclast activity on bone surfaces but can also directly reorganize the bone matrix to improve bone quality through perilacunar/canalicular remodeling; however, the molecular mechanisms remain unclear. We previously found that deleting the transcriptional regulators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-motif (TAZ) from osteoblast-lineage cells caused lethality in mice due to skeletal fragility. Here, we tested the hypothesis that YAP and TAZ regulate osteocyte-mediated bone remodeling by conditional ablation of both YAP and TAZ from mouse osteocytes using 8 kb-DMP1-Cre. Osteocyte-conditional YAP/TAZ deletion reduced bone mass and dysregulated matrix collagen content and organization, which together decreased bone mechanical properties. Further, YAP/TAZ deletion impaired osteocyte perilacunar/canalicular remodeling by reducing canalicular network density, length, and branching, as well as perilacunar flourochrome-labeled mineral deposition. Consistent with recent studies identifying TGF-β as a key inducer of osteocyte expression of matrix-remodeling enzymes, YAP/TAZ deletion in vivo decreased osteocyte expression of matrix proteases MMP13, MMP14, and CTSK. In vitro, pharmacologic inhibition of YAP/TAZ transcriptional activity in osteocyte-like cells abrogated TGF-β-induced matrix protease gene expression. Together, these data show that YAP and TAZ control bone matrix accrual, organization, and mechanical properties by regulating osteocyte-mediated bone remodeling. Elucidating the signaling pathways that control perilacunar/canalicular remodeling may enable future therapeutic targeting of bone quality to reverse skeletal fragility. © 2019 American Society for Bone and Mineral Research.

Indexed as

Bone RemodelingOsteocytesAnimalsBone MatrixMiceOsteoblastsOsteoclastsCOLLAGENGENETIC ANIMAL MODELSMOLECULAR PATHWAYS - REMODELINGOSTEOCYTESTRANSCRIPTION FACTORS

Identifiers

PMID31610061
PMCPMC7066596
OpenAlexW2980517886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.